JP2016521277A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521277A5 JP2016521277A5 JP2016511017A JP2016511017A JP2016521277A5 JP 2016521277 A5 JP2016521277 A5 JP 2016521277A5 JP 2016511017 A JP2016511017 A JP 2016511017A JP 2016511017 A JP2016511017 A JP 2016511017A JP 2016521277 A5 JP2016521277 A5 JP 2016521277A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- formula
- bond
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13165963.3 | 2013-04-30 | ||
| EP13165963 | 2013-04-30 | ||
| PCT/EP2014/058462 WO2014177469A1 (en) | 2013-04-30 | 2014-04-25 | Diaminopyrazine compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016521277A JP2016521277A (ja) | 2016-07-21 |
| JP2016521277A5 true JP2016521277A5 (enExample) | 2017-08-24 |
| JP6353032B2 JP6353032B2 (ja) | 2018-07-04 |
Family
ID=48227015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016511017A Active JP6353032B2 (ja) | 2013-04-30 | 2014-04-25 | ジアミノピラジン化合物、前記化合物を含有する医薬、その使用、およびその調製方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9018215B2 (enExample) |
| EP (1) | EP2991981B1 (enExample) |
| JP (1) | JP6353032B2 (enExample) |
| WO (1) | WO2014177469A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016126721A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | 3-aryl-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
| WO2016126726A1 (en) | 2015-02-02 | 2016-08-11 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as hdac6 inhibitors |
| EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
| GB201610854D0 (en) | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| GB201717051D0 (en) | 2017-10-17 | 2017-11-29 | Enterprise Therapeutics Ltd | Compounds |
| GB201808093D0 (en) | 2018-05-18 | 2018-07-04 | Enterprise Therapeutics Ltd | Compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1663235T1 (sl) * | 2003-08-18 | 2013-12-31 | Parion Sciences, Inc. | Zaščiteni pirazinoilgvanidinski blokatorji natrijevega kanala |
| KR20100005730A (ko) * | 2007-05-07 | 2010-01-15 | 노파르티스 아게 | 유기 화합물 |
| EA017919B1 (ru) * | 2007-12-10 | 2013-04-30 | Новартис Аг | Производные пиразин-2-карбоксамида для лечения заболеваний, которые поддаются лечению путем блокирования эпителиальных натриевых каналов |
| US8859559B2 (en) * | 2011-12-20 | 2014-10-14 | Boehringer Ingelheim International Gmbh | Substituted pyrazines and their use in the treatment of disease |
| JP6204977B2 (ja) * | 2012-05-25 | 2017-09-27 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 三級アミン、前記アミンを含む薬物、その使用及びその調製方法 |
-
2014
- 2014-04-25 JP JP2016511017A patent/JP6353032B2/ja active Active
- 2014-04-25 EP EP14719335.3A patent/EP2991981B1/en active Active
- 2014-04-25 WO PCT/EP2014/058462 patent/WO2014177469A1/en not_active Ceased
- 2014-04-28 US US14/262,903 patent/US9018215B2/en active Active